Wells Fargo analyst Larry Biegelsen upgraded Alcon (ALC) to Overweight from Equal Weight with a price target of $97, up from $88. The firm sees upside to the company’s 2026 guidance, saying new product cycles are starting to benefit Alcon’s growth. The company reported solid Q4 results, driven by new products like Unity and Tryptyr, the analyst tells investors in a research note. Wells says growth from Alcon’s product launches in the past year is starting to materialize and should continue.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALC:
- Alcon upgraded to Overweight from Equal Weight at Wells Fargo
- Alcon price target raised to $92 from $91 at BTIG
- Alcon (ALC): Solid Fundamentals and Market Recovery Support Buy Rating
- Alcon’s 2025 Annual Report Showcases Innovation-Led Growth and Strategic Eye-Care Expansion
- Alcon Posts Strong Q4 2025 Sales Growth and Robust Cash Generation